Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Gene Silencing Market Growth Performance Trended Historically, And What Lies Ahead?
Over the past few years, the gene silencing market has experienced significant expansion. The market size is expected to increase from $5.97 billion in 2024 to $6.69 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.0%. Several factors have contributed to this growth during the historic period, including advancements in genetic therapy research, early successes in RNA interference, an increased prevalence of genetic disorders, and escalating investments in biotechnology. The market’s expansion is also attributed to the growing manufacturing capabilities in the biopharmaceutical sector.
Expectations are high for the gene silencing industry, as projections suggest significant expansion in the coming years. In 2029, the market size is predicted to reach $10.74 billion, with a compound annual growth rate of 12.6%. Factors contributing to this anticipated growth include the increasing implementation of gene silencing in rare disease treatments, advancements in delivery methods, rising demand for personalised medical solutions, favorable government policies, and the strengthening of partnerships within the pharmaceutical and biotech industries. Future trends likely to influence the market further entail targeted gene therapies, the implementation of CRISPR-based silencing methods, a heightened emphasis on rare and orphan diseases, the emergence of technology using nanoparticles for drug delivery, and application of gene silencing procedures in agriculture.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24224&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Gene Silencing Market?
The increasing instances of genetic disorders are projected to drive the expansion of the gene silencing market. Genetic disorders, referring to health issues resulting from DNA anomalies, are being detected more frequently as diagnostic technologies advance, awareness grows, and genetic testing becomes more accessible. The growth in genetic disorders is linked to older parental ages, which raise the likelihood of passing genetic mutations to their children. Gene silencing serves as a potential solution for treating genetic disorders by selectively inhibiting the expression of malfunctioning or disease-inducing genes. For example, as reported by Down Syndrome UK, a charity organization in the UK, in August 2023, around 40,000 people in the UK are affected by Down syndrome, and approximately 1 in every 800 newborns has the condition. Therefore, the rising occurrence of genetic disorders is fueling the development of the gene silencing market.
Which Primary Segments of the Gene Silencing Market Are Driving Growth and Industry Transformations?
The gene silencing market covered in this report is segmented –
1) By Type: Transcriptional, Post-Transcriptional, Meiotic
2) By Gene Silencing: RNA Interference (RNAi), Antisense Oligonucleotides (ASOs), Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing, Other Gene Silencings
3) By Application: Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Other Applications
4) By End-Users: Pharmaceutical And Biotechnology Companies, Research Institutes and Academic Centers, Hospitals, Clinics, Other End-Users
Subsegments:
1) By Transcriptional: DNA Methylation, Histone Modification
2) By Post-Transcriptional: RNA Interference (RNAi), Antisense Oligonucleotides, MicroRNA (miRNA) Mediated Silencing
3) By Meiotic: Meiotic Gene Conversion, Transposable Element Silencing
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24224&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Gene Silencing Market?# Market?
North America was the largest region in the gene silencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene silencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Gene Silencing Market?
Key players in the gene silencing market are concentrating on the advancement of novel technologies like small interfering RNA (siRNA) to improve accuracy and effectiveness in gene therapy. Small interfering RNA (siRNA) is an RNA molecule that significantly contributes to the RNA interference (RNAi) pathway by attaching to distinct messenger RNA (mRNA), facilitating its degradation and inhibiting the creation of disease-causing proteins. For example, in October 2024, Judo Bio Inc., an American biotech firm, introduced a next-generation drug based on small interfering RNA (siRNA) for gene silencing. Distinct features comprise proprietary delivery systems such as lipid nanoparticles or attached ligands ensuring successful absorption by particular cells or tissues, and AI-powered platforms that expedite the finding of feasible gene targets.
View the full report here:
https://www.thebusinessresearchcompany.com/report/gene-silencing-global-market-report
What Parameters Are Used to Define the Gene Silencing Market?
Gene silencing is a biological process in which the expression of a specific gene is reduced or completely turned off. The process is critical in regulating gene activity, controlling development, and defending against viral infections. Gene silencing is essential in research and medicine, particularly for targeting disease-related genes.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24224
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model